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The antigenic complexity of fetal and mature human  kidney has been the subject 
of recent investigation (1-5). Not unexpectedly, fetal kidney has been found to share 
some antigenic determinants with mature kidney (2-5) and to diverge with regard to 
others (1). These studies were facilitated by the characteristic pattern of metanephro- 
genesis whereby relatively mature nephrons are concentrically layered by less mature 
nephrons.  Consequently,  fetal and  infant  kidneys contain  nephrons  at  all stages of 
development,  the  most  primitive residing in  a  subcapsular  location  and  the  most 
mature residing in the juxtamedullary region. 
The  immunohistochemical  probes  used  to  investigate  such  tissues  have  largely 
consisted of heteroantisera and monoclonal antibodies developed after immunizations 
with  renal  tissue  extracts  (1-9).  The  likelihood that  some  antigens  would  remain 
undisclosed by this approach prompted our investigation using monoclonal antibodies 
produced  by  immunization  of mice  with  extrarenal  immunogens.  Specifically, we 
have examined fetal and adult kidney tissues by indirect immunofluorescence using 
monoclonal  antibodies directed against  defined  populations of lymphohemopoietic 
cells. These studies demonstrate a  convergence between antigenic determinants of B 
lymphocytes and leukemic cells on the one hand and epithelial cells of fetal and adult 
kidney on the other, and suggest that acquisition or loss of these determinants can be 
related to the various stages of nephron differentiation and development. 
Materials  and  Methods 
Source of Tissue.  Fetal kidney tissue was obtained from two abortuses each of 11-,  15-,  17-, 
and  21-wk gestations and from one abortus of 18 wk  (estimated by crown-to-rump length). 
Mature human kidney tissue was obtained from normal portions of kidney removed from five 
patients with renal tumors or renal artery stenosis. All tissues were snap-frozen in precooled 
isopentane and stored at -70°C until use. 
Monoclonal Antibodies.  Mouse monoclonai antibodies derived from hybridoma cell lines were 
used to identify renal tissue antigens. Their subclass, specificity, and source are indicated in 
Table I. The following monoclonal immunoglobulins derived from mouse myeloma cell lines 
were used as controls: UPC10  (IgG2a), MOPC  195  (IgG2b), MOPC  104 E  (IgM), and MOPC 
21  (IgGi) (Litton Bionetics, Kensington, MD). 
Immunofluorescence  Techniques.  Kidney  tissues  were  processed  for  immunofluorescence  as 
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TABLE  I 
Source Subclass and Specificity of Monoclonal Antibodies 
Mouse Ig  Specificity  Reference  Antibody  subclass 
TA- 1"  IgG2,  Monocytes  T lymphocytes  10 
OKT3$  IgG~,  T lymphocytes  11 
OKT4$  IgG2b  Helper/inducer T lymphocytes  12 
OKT6$  IgG1  Thymocytes  13 
OKT8$  IgG~a  Suppressor/cytotoxic  T lymphocytes  13 
OKT10$  IgG1  Thymocytes,  activated T cells  14 
OKIa 1  $  IgG2  HLA-DR  15 
BI§  IgG2a  B cells  16 
BA-I*  IgM  B cells, PMN  17 
BA 2*  IgG3  Leukemia-associated  antigen  18 
BA 3*  IgGzb  Leukemia-associated  antigen  19 
JS§  IgG2a  Leukemia-associated  antigen  20 
MBM7*  IgG1  All renal basement membranes  4 
MBM21*  IgG1  Proximal tubule basement membrane  4 
* University of Minnesota, Minneapolis, MN. 
$ Ortho Pharmaceutical Corporation, Raritan, N  J. 
§ Coulter Diagnostics,  Hialeah, FL. 
previously reported (21). 4-#m sections were prepared on a Lipshaw cryostat (Lipshaw Manu- 
facturing  Co.,  Detroit,  MI),  air-dried,  acetone-fixed  for  10  min,  and  then  washed  with 
phosphate-buffered saline (PBS), I pH 7.4. Sections were reacted with the appropriate dilution 
of a monoclonal antibody, washed, and reacted with fluorescein isothiocyanate (FITC)-conju- 
gated F(ab')2 rabbit anti-mouse IgG (heavy and light chains), followed  by FITC-F(ab')2 goat 
anti-rabbit IgG (heavy and light chains) (N. L. Cappel Laboratories, Inc., Cochranville, PA). 
The double fluorochrome layer was used  to  achieve immunofluorescence enhancement, al- 
though specific fluorescence was discernible with a single fluorochrome layer. 
In fetal kidney tissues, four stages of glomerular development were identified: (a) vesicle;  (b) 
S body; (c) developing capillary loop stage;  and (d) mature stage (22). 
Comparison of Renal Antigenic  Distributions.  To compare the location of determinants recog- 
nized by BA-1 with those recognized by BA-2, BA-3, and J5, mixtures of BA-1 with each of the 
other antibodies were prepared at optimal end titer dilution. Renal tissue sections were reacted 
with one of these monoclonal antibody solutions, followed  by a mixture of FITC F(ab')z goat 
anti-mouse IgM ~u chain) (which reacts with BA-1) and tetramethyl rhodamine isothiocyanate 
(TRIC)-conjugated goat  anti-mouse IgG (Fc)  (which identifies J5,  BA-2,  and BA-3)  (N.  L. 
Cappel Laboratories, Inc.) at optimal end titer dilutions. Control sections were reacted with the 
fluorochrome mixture alone without prior application of monoclonal antibodies. 
Location of Antigenic  Determinants at Serial Stages  of Nephrogenesis.  The relationship between 
antigenic expression and ontogenic stage was investigated by reacting fetal and adult kidney 
tissue sections with BA-1, BA-2, BA-3, or J5 and MBM7 (directed against glomerular basement 
membrane  [GBM]  and  tubular basement  membrane  [TBM])  (4), followed  by  a  double 
fluorochrome layer. Localization of antigen in proximal and distal tubules was  determined 
morphologically as well as by staining sections with mixtures of the several anti-B and leukemic 
cell antibodies with MBM21 (which reacts only with proximal TBM). Additional sections were 
reacted with monoclonal antibody, then TRIC F(ab')2 rabbit anti-mouse IgG (heavy and light 
chains) (N. L. Cappel Laboratories, Inc.), followed by FITC rabbit anti-human  Tamm-HorsfalI 
protein (ascending limb of the loop of Henle). The preparation and characterization of FITC 
anti-Tamm-Horsfall antibody has been previously described in detail (3). 
i Abbreviations used in this paper: CALLA, common acute lymphoblastic leukemia antigen; FITC, fluores- 
cein isothiocyanate;  FITC E. coti, fluoresceinated  E. call; GBM, glomerular basement membrane; GVBS  ÷+, 
veronal-buffered saline containing CaC[2, MgCI2, and gelatin; PBS, phosphate-buffered saline; TBM, 
tubular basement membrane; TRIC, tetramethyl rhodamine isothiocyanate. PLATT ET AL.  157 
Characterization  and Relative Tissue Binding of  J5 and BA-3 Antibodies  The locations of J5 and 
BA-3 immunofluorescence  were compared on parallel sections of fetal and adult kidney tissues. 
The differential tissue avidity of J5 and BA-3 was evaluated as follows.  (a) Sections of adult 
kidney tissue were reacted with a mixture of J5 (IgG~) and BA-3 (IgG2u) at optimal end titer 
dilutions, followed  by rabbit anti-mouse IgG~ or rabbit anti-mouse IgGzb (Litton Bionetics) 
and then FITC F(Ab')2 goat anti-rabbit IgG. (b) Sections of adult kidney tissue were reacted 
sequentially in four layers with BA-3, J5, rabbit anti-mouse IgG~, or rabbit anti-mouse IgG2b 
and FITC F(ab')2 goat anti-rabbit IgG; or with J5, BA-3, rabbit anti-mouse IgG~a, or rabbit 
anti-mouse IgG~b and FITC F(ab')2 goat anti-rabbit IgG. (c) To determine whether BA-3 could 
be eluted from kidney by J5, sections of kidney tissue previously reacted with BA-3 for 30 min 
(25°C) were washed with PBS, layered with 20 #1 of J5 at various dilutions, and incubated in 
a  moist  chamber  at  25°C  for  30  min. The  droplet  remaining on  each  section  was  then 
transferred to another acetone-fixed, unstained section of kidney tissue. After incubation for 30 
min (25°C), the section receiving the transferred antibody solution was washed with PBS and 
reacted with rabbit anti-mouse IgG~b (reactive with BA-3) or rabbit anti-mouse IgG~ (reactive 
with J5), followed by FITC F(ab')2 goat anti-rabbit IgG. (d) Sections were reacted with BA-3, 
•  washed, and then reacted with J5  as described above. Before  transfer of the droplet, rabbit 
anti-mouse IgG~,  was  added  to  precipitate  any  remaining J5  and  then  the  droplet  was 
transferred to another tissue section, which was stained for binding of BA-3 with rabbit anti- 
mouse IgG2b, followed by FITC F(ab')2 goat anti-rabbit IgG. 
These studies were controlled and standardized by preparation of tissue sections reacted 
sequentially with  (a)  all antibody layers described above but omitting the first  monoclonal 
antibody layer; (b) BA-3 or J5, rabbit anti-mouse IgG~ or IgG2b, and FITC F(ab')2 goat anti- 
rabbit  IgG;  (c)  BA-3  mixed  with  mouse  myeloma IgG~  (equal  concentration to  that  of 
optimally diluted J5 in milligrams per milliliter), rabbit anti-mouse IgG~, or IgG2b and FITC 
F(ab')2 goat anti-rabbit IgG; (d) BA-3 and PBS or mouse myeloma Ig~a, followed by droplet 
transfer and layering of anti-mouse and anti-rabbit sera as described above. 
C3b Receptor Activity.  The assay of C3b receptor activity on human kidney tissue sections 
using C3b-coated fluoresceinated Escherichia coli (FITC E. coli) has been previously described in 
detail  (23). Briefly,  heat-killed E.  coli  (022:H16)  suspended  in  0.15  M  NaC1  at  5  ×  109 
organisms/ml were added to a  solution of FITC (BBL  Microbiology Systems, Cockeysvilte, 
MD). 0.113  mg/ml of 0.5 M  carbonate/bicarbonate buffer (pH 9.0)  at a ratio of 0.0045  mg 
FITC to 5 ×  109 E. coli. The suspension was incubated for 16 h with gentle agitation and then 
washed four times with veronal-buffered saline (pH 7.5) containing CaC12 (0.15 mM), MgC12 
(1.0 mM), and 0.1% gelatin (GVBS++), and stored at -70°C until use. A suspension was then 
prepared that consisted of equal parts of FITC E. coli and fresh (E. coli-absorbed)  human serum. 
The suspension was  incubated and gently agitated at  37°C  for  15  rain, and washed  with 
GVBS  ÷+ (4°C), and the concentration of organisms was adjusted to 101°/ml. Control suspen- 
sions were prepared as described above containing FITC E. coli in GVBS  ÷+ without addition 
of absorbed human serum or with addition of heat-inactivated (56°C, 30 min) absorbed human 
serum. 
This methodology was adapted to the present investigation by application to unfixed tissue 
sections of MBM7 or mixtures of MBM7 and BA-1, BA-2, BA-3, or OKIal, followed by TRIC 
F(ab')2 rabbit anti-mouse IgG, TRIC F(ab')2 goat anti-rabbit IgG, and then by reaction of 
these sections with C3b-coated FITC E.  coli.  Control preparations included (a)  reaction of 
unfixed tissue sections with C3b-coated FITC E. coli without prior application of antisera, and 
(b) reaction of fluorochrome-stained and unstained tissue sections with FITC E. coli suspensions 
prepared without addition of human serum or with addition of heat-inactivated (56°C, 30 
min) E. coli-absorbed  human serum. 
Immunofluorescence Microscopy.  To retard the fading of fluorescence,  p-phenylenediamine in 
PBS-glycerol  was applied to fluorochrome-stained sections (24). Separate studies using these 
and other antisera on human kidney tissue revealed no effect  of this compound on antibody 
specificity (.J. Platt, unpublished observation). Tissues were examined with a Zeiss Universal 
microscope (Carl Zeiss, Inc., New York) equipped for epifluorescence with appropriate filters 
and dicroic mirrors. 
Standardization  of Reagents and Immunofluorescence Controls.  The appropriate dilutions of mono- 158  STAGES OF RENAL ONTOGENESIS 
clonal antibodies were determined  using the amplified  immunofluorescence method described 
above on frozen sections of human lymphoid or renal tissue. Mouse myeloma antibodies  were 
used at dilutions  that approximated the optimal dilution  of hybridoma-derived  antibodies  in 
milligrams of purified Ig per milliliter. Immunofluorescence controls included the following. (a) 
Each  tissue was  reacted  with  the  various  combinations  of FITC-conjugated  and  TRIC- 
conjugated  reagents without prior application  of monoclonal antibodies.  (b) Where mixtures of 
monoclonal or polyclonal antibodies were used, control sections were prepared on which these 
antibodies were layered sequentially.  (c) Fc receptor  binding was excluded by the application 
of mouse myeloma antibodies of the same Ig subclass as the hybridoma-derived  antibodies used 
in  the  study,  by the use of F(ab')2 fluorochromes  whenever  possible, and by preparation of 
control sections on which the last fluorochrome layer applied consisted of F(ab')2 antibody. The 
controls used in studies comparing J5 and BA-3 are described in detail above. 
Results 
Thymic and Mature T  Cell Antigens.  Fetal and adult  kidney tissues  were examined 
for the presence of thymic and mature T cell antigens using the following monoclonal 
antibodies:  TA-1  (monocytes and T  cells),  OKT3  (mature thymocytes and T  cells), 
OKT4 (common and mature thymocytes and helper/inducer T  ceils),  OKT8 (com- 
mon  and  mature  thymocytes and  suppressor/cytotoxic T  cells),  OKT6  (common 
thymocytes), and OKT10 (early, common, and mature thymocytes and activated T 
and B lymphocytes). No reactivity of glomerular, tubular, or vascular structures was 
noted. However, each monoclonal reagent reacted with occasional interstitial  cells in 
fetal and adult tissues.  In general, these cells  in  11-, 15-, and  18-wk fetuses were large 
(similar  in  size  to  monocytes)  and  weakly  fluorescent.  Some  mononuclear  cells 
identified  by OKT6  at  11  wk  and  OKT10  at  11  and  15  wk  appeared  to  contain 
phase-dense cytoplasmic granules. Tissue sections of the  18-wk fetal kidney contained 
a few smaller mononuclear cells that were reactive with OKT4 and OKT 10. In 21-wk 
fetal  kidney  tissue,  each  of the  antibodies  identified  interstitial  cells  of small  and 
moderate size that were greater in number and staining intensity than those observed 
in more primitive tissues. 
BA-1.  BA-1 is known to identify a  cell surface antigen expressed by normal and 
malignant B cells  at multiple stages of differentiation and also by granulocytes (17). 
In sections of fetal kidney, it reacted with all cells of the primitive subcortical nephron 
and ureteral  bud  (vesicle  and S-body stages)  (Fig.  1).  Glomerular development was 
characterized by loss of antigen from the visceral glomerular epithelium and proximal 
tubule  (Figs.  1 and  2).  Thus,  fetal  tissues  of all  gestations  displayed  a  gradient  of 
immunofluorescence  for  BA-1  such  that  primitive  subcortical  nephrons  appeared 
intensely and diffusely stained, whereas centripetal fields  (and adult tissues)  revealed 
relatively weak fluorescence restricted to Bowman's capsule epithelium and the distal 
nephron (Fig.  1). The antigen in the vesicle  and S body seemed to be associated with 
the  plasma  membrane,  whereas  that  of more  mature  tubules  was  located  in  the 
cytoplasm and brush border. 
To determine more precisely which mature tubules were identified by BA- 1 sections 
of adult  kidney tissue  were  reacted  with  BA-1  and  counter-stained  with J5,  BA-3 
(proximal tubular epithelium), or MBM21  (basement membrane of proximal tubule 
and loop of Henle), followed by TRIC goat anti-mouse IgG (Fc), or with FITC rabbit 
anti-Tamm-Horsfall  protein  (epithelium  of thick  ascending  limb  and  early  distal 
tubule). These studies revealed that BA-1 was located in the distal part of the nephron 
by virtue of (a) lack of association with proximal tubules having reactivity for J5 and PLATT  ET  AL.  159 
FtG.  1.  BA-1  reactivity of fetal (A-C) and adult (D) human kidney tissue.  (A) Primitive vesicles, 
S forms, and ureteral bud structures  near renal capsule (arrowheads)  identified by BA- 1 in an  11- 
wk fetus. In more developed glomeruli in the deep cortex, reactivity is limited to Bowman's capsule 
and distal nephron  (X 70). (]3) An early vesicle form in an  1  l-wk fetal tissue is reactive with BA-I 
in cells of the ureteral bud  (above  U) and in the mesenchyme (below M) condensing about  it. A 
more developed glomerulus (G) has reactive parietal epithelium (×  115). ((2) Early capillary loop 
stage in 21-wk fetal kidney stained with a mixture of BA-1 and a monoclonal antibody to human 
renal basement membrane (MBM7).  MBM7 identifies  Bowman's capsule and GBM (arrowheads). 
At  this  stage,  parietal  epithelium is reactive with BA-1, whereas visceral  epithelium has  lost  or 
nearly lost  (arrow)  reactivity with this  antibody. An adjacent distal tubule C  I')  is highly reactive 
with BA-1 (× 445). (D) BA-1 fluorescence of mature human kidney tissue is limited to the parietal 
epithelium of Bowman's capsule (arrow)  and a distal tubule CI'). A granulocyte in the glomerulus 
(G) is also identified (× 445). 
BA-3;  (b)  infrequent  expression  on proximal  cortical tubules  against  which  MBM21 
is  directed;  (c)  association  with  some  medullary  tubules  containing  Tamm-Horsfall 
protein  (although  most tubules reacting with BA-1 were located in a  more distal site). 
Anti-B1.  Anti-B1  antibodies  recognize a  population  of B  cells that  is functionally 
and  developmentally  similar  to  that  identified  by  BA-1  (•6).  Although  interstitial 
cells reactive with  anti-B1  were  noted  in  kidney  tissues  as  early  as  15  wk  gestation, 
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Flo. 2.  Reactivity  of parietal and presumptive parietal epithelium (hatched bars) and visceral 
and presumptive visceral epithelium (open bars) in developing human glomeruli with monoclonal 
antibodies BA-1, BA-2, and BA-3/J5 and with human C3b-coated E.  coll. Four developmental 
stages of fetal glomeruli (vesicle form, S body, early capillary loop, and mature) are indicated as 
previously described (22). Acquisition of a human GBM antigen (reactive with monoclonal  antibody 
MBM7) is shown for reference (solid bar). 
wk tissues,  granular B 1 fluorescence was noted in the cytoplasm of ureteral bud and 
collecting duct epithelium. Parenchymal reactivity was not observed in normal adult 
human kidney. 
BA-2.  BA-2 antibody is known to react with most acute lymphoblastic leukemia 
cells  (18),  as well as with a  large number of human tumors of epithelial  and neural 
crest  origin  (T.  LeBien,  unpublished  observations).  In  fetal  tissue,  ureteral  bud 
structures revealed intense fluorescence. Glomerular and tubular reactivity were first 
noted in the S body after capillary invasion. The vesicle and primitive S form were 
unreactive  (Fig.  3).  Development of the  nephron  was  associated with  gradual  but 
incomplete disappearance of reactivity from the visceral glomerular epithelium and 
proximal  tubule  and  with  persistence  in  epithelial  cells  of Bowman's capsule  and 
distal tubule (Figs.  2 and 3). Immunofluorescence in adult kidney tissue was intense 
along the inner aspect of Bowman's capsule and tubular segments distal to the distal 
convuhed tubule, where individual tubular cells or internal and apical cell membranes 
were notably identified. A moderate number of interstitial mononuclear cells displayed 
plasma  membrane  fluorescence.  Fetal  as  well  as  adult  arterial  smooth muscle  and 
capillaries also reacted with BA-2. 
J5 and BA-3.  J5 and BA-3 antibodies are both directed against the common acute 
lymphoblastic leukemia antigen (CALLA) (19, 20). The immunofluorescence pattern 
of each antibody on renal tissue sections was indistinguishable from that of the other. 
The  most  primitive  of glomeruli  at  vesicle  and  S-body  stages  were  consistently 
unreactive with BA-3 and J5 (Fig. 4). In contrast, the antibodies distinctly stained the 
visceral  epithelium  of  more  mature  fetal  and  adult  glomeruli  (Figs.  4  and  5). 
Additionally,  BA-3 and J5  reacted  with  the brush  border of the  proximal  tubules 
associated with the more mature nephrons. The glomerular endothelium, basement 
membrane, parietal epithelium, and distal tubule of fetal and adult kidney tissue were 
never reactive with BA-3 or J5. 
To  determine  the  relationship  between  glomerular  development  and  epithelial 
expression of CALLA, sections of fetal kidney tissue were reacted with BA-3 or J5 and 
counter-stained with MBM7  (directed against GBM, TBM, and Bowman's capsule). 
These  studies  revealed  that  BA-3  and  J5  reactivity  was  confined  to  glomerular 
epithelial cells closely associated with basement membrane and confirmed the absence PLATT ET  AL.  161 
FlO.  3.  Reactivity of fetal (A-C) and mature (D) kidney tissues with BA-2. (A) 21-wk fetal kidney 
tissue in which primitive ureteral bud elements at outer cortex (arrowheads)  are intensely reactive 
with BA-2. In more mature nephrons in the deep cortex, Bowman's capsule and distal tubules are 
most  notably reactive (×  70). (B) S form in  21-wk fetal kidney tissue  is identified by BA-2. The 
associated  ureteral bud below (U) and to the left is also reactive (X 445). (C) Capillary loop-stage 
glomerulus in  18-wk fetal kidney has BA-2 fluorescence  along parietal epithelium. Fluorescence  of 
visceral epithelium is beginning to wane. Adjacent distal tubules are also reactive for BA-2 (X 445). 
(D) Adult kidney tissue reacted with BA-2 reveals fluorescence of parietal epithelium of Bowman's 
capsule (arrow) and weak reactivity of the visceral epithelium in the glomerulus (G). Two arterioles 
(a) contain smooth muscle reactive with BA-2. The epithelium of a distal  tubule (T) is also reactive 
(X 445). 
of epithelial  staining  before  basement  membrane  formation  (Fig.  2).  Furthermore, 
CALLA  fluorescence was most intense at  the lateral and  apical aspects of epithelium 
in  direct  contact  with  basement  membrane.  No  glomeruli  that  evidenced  CALLA 
lacked identifiable GBM;  however, in some primitive glomeruli, CALLA  was identi- 
fied  on  the  more  centrally  located  visceral  epithelium  and  not  on  the  peripheral 
visceral epithelium  (Fig. 4). 
Sections  of adult  and  fetal  kidney  stained  with  BA-3  or J5  were  counter-stained 
with  MBM21,  BA-1,  and  rabbit  anti-human  Tamm-Horsfall  protein.  All  tubules 
reactive  for  CALLA  were  also  reactive  for  MBM21.  The  point  at  which  CALLA 162  STAGES  OF  RENAL  ONTOGENESIS 
FIG. 4.  BA-3 reactivity with 21-wk kidney fetal tissue.  (A) Relatively mature nephrons in the inner 
cortex are reactive with BA-3, whereas primitive nephrons adjacent to the renal capsule (arrowheads) 
are  not  (×  70).  (B)  Fetal  kidney  tissue  reacted  with  MBM7  directed  against  renal  basement 
membranes  (arrowheads  denote  GBM  and  Bowman's  capsule)  and  also  with  BA-3.  An  early 
capillary loop stage glomerulus (right) contains some visceral epithelium, which is developing BA- 
3 reactivity (arrow),  whereas epithelium associated with the upper capillary loop (asterisk  denotes 
capillary lumen) is unreactive. An adjacent S  form  (S)  does  not react with BA-3 (× 445).  (C)  A 
more  mature  capillary  loop-stage  glomerulus  containing BA-3  reactive  visceral  epithelium  in 
proximity to capillary loops (asterisks denote capillary lumina); the afferent/efferent arteriole (a) is 
not reactive, whereas the brush border of a proximal tubule f'f) demonstrates striking fluorescence 
(X  445).  (D)  A  maturing capillary  loop-stage  glomerutus  whose  basement  membranes  (GBM, 
Bowman's capsule) are identified by MBM7 (arrowheads), Abundant visceral epithelium surround- 
ing capillary loops  (asterisks)  is reactive with BA-3, whereas the parietal epithelium is not. Below 
the glomerulus are two tubules (T): a proximal tubule, whose brush border is identified by BA-3 
and the underlying basement membrane by MBM7; immediately beneath the proximal tubule is 
a distal tubule whose basement membrane is reactive with MBM7 (X 445). 
antigen ceased to  be present was observed on several  fortuitous longitudinal  sections 
of descending  tubules.  Most  medullary  tubules  were  reactive with  MBM21  but  not 
with J5  or BA-3.  Tubules  with  CALLA  fluorescence  were  not  reactive with  BA-1  or 
anti-Tamm  Horsfall protein antibodies. 
Prior investigations have suggested that J5  and  BA-3 are directed against the same 
epitope of the common  acute lymphoblastic  leukemia  antigen, J5  having  the greater PLATT  ET  AL.  163 
FIo.  5.  Reactivity of mature glomerulus with J5.  (A)  Immunofluorescence photomicrograph of 
mature glomerulus reacted with J5. (B) Immunofluoreseenee photomicrograph of the same glomer- 
ulus with phase-contrast enhancement to identify capillary lumina (asterisks)  surrounded by phase- 
dense glomerular basement membrane and J5-reaetive visceral epithelium (E). The mesangia (M) 
and arteriolar pole (a) are unreactive. An adjacent glomerulus (G) reveals similar features (x 665). 164  STAGES OF  RENAL ONTOGENESIS 
affinity (19).  Our findings that support this hypothesis include the following:  (a) the 
distribution  of renal  determinants recognized by the two antibodies is the same;  (b) 
kidney  tissue  sections  reacted  with  a  mixture  of optimally  diluted  J5  and  BA-3 
antibodies reveal intense J5 and minimal BA-3 fluorescence;  (c) the application of  J5 
to tissue sections previously reacted with BA-3 abolishes BA-3 reactivity, whereas BA- 
3 application to sections previously reacted with J5 does not affect the intensity of J5 
fluorescence; (d) that BA-3 is eluted from tissue rather than masked by application of 
J5 was conclusively shown by droplet transfer experiments which consistently revealed 
the  presence  of BA-3  antibodies  in  the  eluted  droplet  and  enhancement  of BA-3 
reactivity by immunoabsorption of JS. 
HLA-DR.  HLA-DR antigen  was detected  in  adult  kidney tissue on per.itubular 
capillaries and glomerular endothelium  and mesangium as previously reported  (25- 
27),  The expression of this antigen in fetal kidney tissues varied with the gestational 
age of the  fetus.  In early gestation  (11  wk), weak focal  fluorescence of peritubular 
capillaries and focal segmental fluorescence of glomerular capillaries was observed. At 
15 wk, mesangial reactivity was first noted. With advancing gestational age, a greater 
proportion  of glomerular  and  peritubular  capillaries  reacted  with  OKIal  and  the 
fluorescence appeared progressively more intense (Fig. 6). The expression of HLA-DR 
antigen did not correlate with the stage of nephron development. The vesicles and S 
bodies in more mature fetuses (21 wk) were surrounded by Ia-reactive capillaries and 
the earliest evidence of capillary in-growth was witnessed as distinct capillary reactiv- 
ity at  the proximal crevice of the  S  body, whereas the  vesicles and  S  bodies in  less 
rnatnre fOtl|~eo, reveMert nnlv weak faeal  ~Innre~rence, in  tho~o lnentlan~  ,'~nna~" rnllnt'-] 
FIG. 6.  Fetal  kidney tissue (21-wk) reacted with a monoclonal antibody (OKIal) that recognizes 
human Ia-like antigen. Outer cortex (arrowheads) contains primitive glomeruli and one distinct S 
form (S)  surrounded by capillaries and interstitial cells, some of which are weakly fluorescent. 
Centrifugally located more mature glomeruli (G) contain capillaries, a variable proportion of which 
react with OKIal (× 560). PLATT ET AL.  165 
cells at  the center of primitive  glomeruli displayed Ia reactivity along the plasma 
membrane, as did large round interstitial cells that  appeared to be associated with 
peritubular capillaries. Sections of fetal kidney to which a mixture of BA-3 and OKIal 
was applied revealed some primitive glomeruli in which capillary staining for Ia was 
observed without evidence of CALLA expression by the contiguous visceral epithe- 
lium. 
C3b  Receptor.  The  relationships  between  gestational  age,  metanephric  develop- 
ment, and glomerular C3b receptor activity were examined in  fetal kidney tissues. 
Unfixed tissue sections were reacted sequentially with MBM7  (basement membrane 
marker) or OKIal or mixtures of MBM7 and BA-1, BA-2, or J5, followed by a double 
fluorochrome layer (TRIC) and finally with C3b-coated FITC E. coil 
C3b  receptor activity, indicated by glomerular aggregation of FITC E.  coli,  was 
observed in all tissues examined (11 wk gestation to adult). In fetal tissues, aggregation 
was only noted in glomeruli with well-developed basement membranes (as indicated 
by MBM7 reactivity) and was not present at the vesicle and S-body stages (Fig. 2). 
In fetal tissues stained with BA-1/MBM7 or BA-2/MBM7 mixtures and FITC E. 
coli, C3b receptors were not observed in the subcortical vesicles and S forms intensely 
reactive with  BA-1  and  BA-2.  In  contrast,  fetal kidney reacted with  a J5/MBM7 
mixture revealed that all glomeruli having FITC E. coli aggregates were reactive with 
J5.  However,  the  converse was  not  observed  in  that  some  less  mature  glomeruli 
containing visceral epithelium weakly reactive with J5 did not evidence C3b receptors. 
In  tissue sections prepared with OKIal  and  FITC E.  coli,  aggregates were noted 
only in glomeruli having substantial OKIal fluorescence. Primitive glomeruli contain- 
ing little OKIal reactivity did not appear to have C3b receptors. 
Control studies  failed to reveal any inhibition  of C3b  receptor activity by prior 
binding of monoclonal antibodies. 
Discussion 
The studies reported here demonstrate that a series of monoclonal antibodies that 
recognize cell surface molecules expressed on B cells and leukemic cells also identify 
well-defined stages of metanephric development. Furthermore, the pattern of meta- 
nephric cell differentiation can be related to the acquisition of a GBM antigen and a 
C3b receptor activity, but less clearly to the expression of Ia-like antigen. 
Human metanephric development begins during the fifth week of gestation. It is 
characterized by aggregation of nephrogenic mesenchyme opposite branches of the 
ureteral bud (vesicle stage), formation of the primitive S body consisting of presump- 
tive glomerular and tubular epithelium, followed sequentially by capillary ingrowth, 
GBM  formation,  and  differentiation of glomerular parietal,  visceral,  and  tubular 
epithelium. Development proceeds in a centrifugal fashion as newly forming glomeruli 
are layered in apposition to more mature glomeruli. Thus, from the eighth gestational 
week, fetal kidney tissue is found to contain nephrons at all stages of development. 
Most prior immunohistologic studies (1-3, 6-9) of the developing kidney have used 
heteroantisera derived from immunization with renal tissue extracts to demonstrate 
the presence of antigens expressed at various developmental stages by the glomerular 
epithelium, basement membrane, and tubular epithelium. These studies have dem- 
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gens  was  necessarily  limited  to  immunogenic  determinants  not  expressed  on  the 
various extrarenal tissue extracts used for immunoabsorption (1). 
Affinity-purified  heteroantisera  directed  against  well-characterized  antigens  ex- 
tracted  from nonrenal  tissues have been  very useful  in  locating extracellular  renal 
differentiation  antigens such as type IV collagen, fibronectin,  and laminin  (28-30). 
However, this approach requires prior identification and purification of the antigen. 
The use of monoclonal  antibodies  to identify renal  tissue  antigens  (4)  obviates the 
removal of potentially useful antibodies by immunoabsorption, assures specificity of 
the antibody probe, and permits use of antibodies against cellular antigens that are 
more readily characterized functionally than biochemically. However, these investi- 
gations have used antibodies produced by immunizations with renal tissue antigens 
and thus were limited by the immunogenicity of the extracts. 
In  this  study  we  have  used  a  number  of monoclonal  antibodies  derived  from 
immunizations of mice with human lymphohemopoietic cells to investigate the extent 
to which antigens expressed by well-characterized populations of lymphoid cells are 
concomitantly expressed in fetal and mature kidney tissue. One previous report (31) 
and our coincidental observations (21)  suggested that this approach could be reveal- 
ing. 
Reaction of fetal and adult kidney tissues with monoclonal antibodies that recognize 
T  cells  (OKT3,  TA-1),  T  cell  subsets  (OKT4,  OKTS),  and  thymocytes  OKT6, 
OKT10) did not reveal renal parenchymal fluorescence. These antibodies did identify 
occasional  interstitial  cells,  which  were  generally  larger,  more  numerous,  and  less 
intensely fluorescent in  fetal than in adult  tissues.  These cells may be precursors of 
mature  lymphoid  cells,  which  sparsely  populate  normal  mature  interstitium  (21). 
However,  their  identity  as  such  cannot  be  proven  without  investigation  of  the 
functional  correlates of their plasma membrane antigens.  Still,  it  is of interest  that 
renal tissues from fetuses of ll-18-wk gestations contained notably more interstitial 
cells that reacted with antibodies directed against thymocytes (OKT6, OKT 10) than 
did more mature tissues. 
The application of antibodies  that  recognize leukemia-associated antigens  (BA-2, 
BA-3, and J5) and B cell antigens (BA-1  and anti-B 1) resulted in striking immunoflu- 
orescence of fetal  and  adult  kidney tissues.  BA-1  reacted  with  all  immature  renal 
epithelia and the ureteral bud.  Nephron  development was characterized  by abrupt 
loss ofBA-1 from all but glomerular parietal epithelium and distal tubular epithelium. 
Loss  of BA-1  fluorescence  was  associated  with  the  appearance  of immunoreactive 
GBM  and  acquisition  by  visceral  epithelium  of CALLA.  BA-2  reacted  with  all 
ureteral  bud  epithelium  and  with  glomerular and  tubular  epithelia  after capillary 
invasion of the S body. BA-2 fluorescence of visceral glomerular and proximal tubular 
epithelia gradually diminished with nephron maturation. These patterns of BA-1 and 
BA-2  reactivity  were  observed  in  fetal  tissues  of all  gestations  and  thus  reflected 
nephron differentiation rather than duration of gestation (Fig. 2). 
Anti-B 1 antibody reacted with the ureteral bud and some distal tubules of 21-wk 
fetal kidney tissues.  Parenchymal fluorescence was not observed in kidneys from less 
mature fetuses or in the five mature human  kidney tissues to which  it was applied. 
Distal  tubular reactivity was noted,  however, in  one diseased  adult  tissue  (J.  Platt, 
unpublished observation). Occasional interstitial cells were identified by B 1 at gesta- PLATT ET AL.  167 
tions of-----15  wk. Thus, the occurrence of B1 antigen appears developmentally related 
but gestationally limited. 
The patterns of immunofluorescence observed with J5 and BA-3 antibodies were 
indistinguishable. Both antibodies reacted with the visceral epithelium of the glomer- 
ulus and the brush border of the proximal tubule. These data are consistent with a 
previous  report  of J5  reactivity  in  renal  tissue  (31).  Expression  of  the  antigen 
recognized by J5 and BA-3 was distinctly related to glomerular differentiation rather 
than gestation because antigenic distribution was the same in all fetal tissues (Fig. 2). 
Fluorescence was never observed at the vesicle and early S-body stages before GBM 
formation, but appeared first on glomerular visceral epithelial surfaces in proximity 
to the developing basement membrane recognized by a monoclonal antibody, MBM7. 
In  more  mature  glomeruli, j5  and  BA-3  identified  all  visceral  epithelium.  The 
presence  of J5/BA-3-positive  and  -negative  epithelium  contacting  the  basement 
membrane in the same glomeruli suggests that CALLA expression occurs shortly after 
the GBM is formed. The glomerular polyanion, an epithelial cell surface sialoprotein, 
is also recognized early in the S-body stage of developing glomeruli (29,  32). 
There are data that indicate that BA-3 and J5 are directed against the same epitope 
of the common acute lymphoblastic leukemia antigen, J5 having the greater affinity 
(19). Out studies of comparative tissue binding lend strong support to this contention. 
The expression of HLA-DR in fetal and adult tissues was examined using OKIal 
antibodies that recognize a monomorphic determinant on human Ia-like, cell-surface 
glycoproteins. Prior investigation of Ia-tike antigen distribution in the mature human 
kidney have used heteroantisera (25)  and monoclonal antibody probes (26, 27). Our 
studies of adult  kidney tissue yielded results similar to these reports: HLA-DR was 
detected on the glomerular capillary loops, endothelium of intraglomerular arterioles, 
mesangium, and peritubular capillaries. 
OKIal reactivity was observed in all fetal tissues examined, the extent and fluores- 
cence intensity increasing progressively with gestational age. Reactivity was sparsely 
distributed in  11-wk tissues occurring in focal segmental glomerular capillary loops 
and  along  some  peritubular  capillaries.  The  antibody  also  identified  round  cells 
associated with capillaries in the glomeruli and interstitium. These may be developing 
endothelial cells or lymphohemopoietic cells. Mesangial fluorescence was first noted 
in 15-wk fetal tissues. In 21-wk tissues, reactivity was noted in glomerular endothelia, 
mesangia,  and  peritubular  capillaries.  Thus,  HLA-DR  expression  appeared  to  be 
related more to gestation than developmental stage. 
The presence of receptors for C3b on the visceral epithelium of the glomerulus has 
been investigated using C3b-coated erythrocytes (33-36), bacteria  (23,  37, 38),  im- 
mune complexes (39), and monoelonal antibodies (40, 41), and has been reported to 
occur in human fetal kidney as early as the  t 2th gestational week. We investigated 
the  association  of C3b  receptor activity with  the  antigenic  characteristics of fetal 
glomeruli using C3b-coated, fluoreseein-labeled E.  coli applied to tissue sections that 
had  been  reacted  with  BA-1,  BA-2,  OKIal,  and J5.  These studies  indicated  that 
development of C3b receptors is related to nephron differentiation and not gestation 
because mature glomeruli in all tissues examined evidenced C3b receptors, whereas 
the most immature glomeruli did not. Additionally, the expression of C3b receptors 
was associated with loss of BA-1  and BA-2 reactivity and acquisition of CALLA by 
visceral epithelium as follows. (a) Early-developing capillary loop-stage glomeruli with 168  STAGES OF  RENAL ONTOGENESIS 
C3b  E.  coli  aggregates  had  little  visceral  epithelial  reactivity  for  BA-1  and  BA-2, 
whereas  more  primitive  glomeruli  strongly  reactive  with  these  antibodies  never 
evidenced C3b receptors. (b) All glomeruli with C3b E. coli aggregates reacted with J5 
and BA-3, whereas some immature glomeruli having segmental J5 fluorescence had 
no aggregation of C3b E. coll. It would thus appear that the epithelium of developing 
glomeruli sequentially acquire CALLA, lose BA-1  (and some BA-2)  reactivity, and 
then  acquire  C3b  receptors.  That  BA-1  and  BA-2  antibodies  did  not  block  C3b 
receptor activity was  indicated  by the observation  that  glomeruli with  C3b  E.  coli 
aggregates were similarly located on parallel sections with and without  prior appli- 
cation of BA-1 and BA-2. 
It is reasonable to ask whether any of the antigens we have described in fetal and 
adult  tissues are filtered  at  the  glomerulus and  adsorbed  to epithelial  cell surfaces. 
This explanation  is  not  likely to  account  for early fetal expression  of the  antigens 
recognized by BA-1, BA-2, and anti-B 1 because these antigens occur most dramatically 
on the distal nephron before capillary invasion of the S body and connection of the 
ureteral bud to the primordial distal nephron.  CALLA could be filtered by mature 
glomeruli and adsorbed to visceral epithelium.  However, the segmental fluorescence 
of developing glomeruli and the known sieving properties of mature glomeruli  (42, 
43) suggest that the antigen is not simply filtered and adsorbed.  On the other hand, 
we  cannot  exclude  the  possibility  that  tubular  reactivity with  these  antibodies  in 
mature kidneys results from adsorption of antigens shed by the glomerulus (44). 
In view of prior observations that glomeruli contain C3b and perhaps Fc receptors 
(33-41),  could  our  immunofluorescence  findings  reflect  nonspecific  or  Fc  receptor 
binding  of the  mouse  monoclonal  antibodies?  We  have  examined  all  tissues  with 
mouse myeloma antibodies of the same immunoglobulin subclasses as the hybridoma 
antibodies  used  and  have  not  seen  tissue  reactivity.  The  absence  of parenchymal 
staining  with  anti-T  cell  antibodies  and  the  use  of F(ab')  fluorochromes  serve  as 
additional  controls.  Finally,  the  clearly distinguishable  pattern  of fluorescence  ob- 
tained with each monoclonal antibody argues further against nonspecific reactivity. 
Assuming  the  immunofluorescence  findings  we  have  described  reflect  a  specific 
antibody-antigen reaction, there remains an important question:  are the monoclonal 
antibodies  reacting with  identical  macromolecules or fragments of macromolecules 
commonly expressed by lymphohemopoietic cells and renal parenchyma, or are our 
immunofluorescence findings a  consequence of shared epitopes of dissimilar macro- 
molecules  (45)?  Others  (25)  have  isolated  and  characterized  Ia-like  antigen  from 
human kidney tissues. Furthermore, a J5-reactive molecule with a molecular mass of 
-90,000 daltons has been isolated from human kidney (31). We can provide no direct 
evidence that the antigens identified by BA-1 and BA-2 in fetal kidney are identical 
to those located  on lymphohemopoietic cell surfaces.  However, preliminary experi- 
ments with BA-2 indicate that a  molecule of ~24,000  daltons, similar to that of p24 
precipitated from leukemic cells with BA-2 (18), can be detected in human urine (T. 
LeBien and J. Platt, unpublished observations). 
Our investigations have suggested that an antigenic convergence exists between B 
cells  and  leukemic cells on  the  one hand  and  parenchymal  structures  in  fetal  and 
adult  kidneys on the other.  Such  convergence is  not evident  for the six anti-T cell 
antibodies  studied.  This  observation  is  of interest  because  stem  cells  common  to PLATT ET AL.  169 
myeloid and  B  lymphocytic lines  have  been  recognized  (46),  whereas  a  stem  cell 
common to B and T  lymphocytes has not been identified. 
It is intriguing that glomerular epithelium and lymphohemopoietic cells share at 
least four differentiation antigens, have plasma membrane C3b and Fc receptors, and 
reside in a microenvironment enriched for endothelial HLA-DR antigen and accessory 
cell function (47).  Because studies in lower vertebrates have suggested that lympho- 
hemopoietic stem  cells may arise  in  proximity to  nephrogenic  mesoderm  (48-52), 
there is reason to inquire whether lymphoid cells or their progenitors share unrecog- 
nized physiologic functions or ontogenic experiences with renal cells. 
Summary 
Differentiation antigens of T  and B lymphocytes were sought in human fetal and 
adult kidney tissues with monoclonal antibodies by indirect immunofluorescence. 
Antibodies  that  identify  B  cells  (BA-1  and  anti-B1)  and  leukemia-associated 
antigens (BA-2, BA-3, and J5) reacted with renal glomerular and tubular epithelium 
at characteristic stages of nephron development. BA-1 and BA-2 identified primitive 
epithelium  of the  glomerulus,  and  ureteral  bud  and  nephron  development  was 
characterized by loss of BA- 1 and BA-2 binding by visceral glomerular and proximal 
tubular epithelium. In contrast, J5 and BA-3 did not react with primitive epithelium 
but  identified  visceral  and  proximal  tubular  epithelium  after  appearance  of the 
glomerular basement membrane and throughout subsequent nephron differentiation. 
Anti-B1  reacted with  ureteral bud  and  distal  nephron epithelium  in  more mature 
fetal tissues. 
Monoclonal antibodies that identify populations ofT cells and thymocytes did not 
react with parenchymal cells of fetal or adult kidneys. They did identify interstitial 
mononuclear cells whose size and relative numbers appeared gestationally related. 
Monoclonal antibodies that recognize a  human monom0rphic HLA-DR determi- 
nant reacted with glomerular and peritubular capillaries as early as 11 wk of gestation. 
The  distribution  and  density  of HLA-DR  expression  appeared  more  related  to 
gestation than nephron development. 
The  relationship  between  renal  parenchymal  expression  of lymphohemopoietic 
antigens and glomerular acquisition of C3b receptor activity was determined using 
C3b-coated  fluoresceinated  Escherichia  coli.  In  fetal  tissues,  C3b  receptor  activity 
appeared developmentally related to the loss of determinants recognized by BA-1 and 
BA-2  and  to  the  appearance  of J5  and  BA-3  reactivity with  visceral  glomerular 
epithelium. 
Tissue binding and comparative avidity of  j5 and BA-3 antibodies was studied in 
a series of experiments, the results of which suggest that these antibodies are directed 
against  the same epitope or closely related epitopes of the common acute lympho- 
blastic leukemia antigen. 
The common expression of differentiation antigens and C3b receptors by cells of 
lymphohemopoietic lineage and renal epithelia suggests the possibility of heretofore 
unrecognized commonality of function or developmental experience. 
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